Soleus Capital Management’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-79,600
Closed -$19.5M 98
2025
Q2
$19.5M Buy
+79,600
New +$19.8M 1.29% 25
2024
Q3
Sell
-44,356
Closed -$16.6M 95
2024
Q2
$16.6M Sell
44,356
-27,650
-38% -$9.34M 1.46% 27
2024
Q1
$25M Sell
72,006
-1,700
-2% -$644K 1.85% 13
2023
Q4
$33.7M Buy
73,706
+4,904
+7% +$2.42M 3.74% 7
2023
Q3
$33.5M Buy
68,802
+6,052
+10% +$2.84M 3.09% 8
2023
Q2
$28.1M Buy
62,750
+39,000
+164% +$19.6M 3.12% 10
2023
Q1
$11.5M Sell
23,750
-3,000
-11% -$1.48M 1.19% 25
2022
Q4
$13.7M Buy
26,750
+12,550
+88% +$6.6M 1.97% 20
2022
Q3
$6.89M Buy
+14,200
New +$6.91M 0.94% 32
2020
Q3
Sell
-6,600
Closed -$2.56M 67
2020
Q2
$2.56M Buy
+6,600
New +$2.47M 1.46% 26
2020
Q1
Sell
-5,800
Closed -$2.13M 55
2019
Q4
$2.13M Buy
+5,800
New +$1.84M 2.05% 18

Other funds holding HUM

Soleus Capital Management's HUM Position: Q3 2025 in Review

Soleus Capital Management sold out of Humana (HUM) in Q3 2025, closing a stake of 79,600 shares — an estimated $19.5M sold.

Soleus Capital Management first reported a position in HUM in Q4 2019 and held it in 11 quarters. The position peaked at $33.7M in Q4 2023. 890 funds tracked by Wall St. Rank hold HUM as of Q3 2025.

  • Soleus Capital Management reported no remaining Humana position as of Q3 2025 after selling out during the quarter.
  • Soleus Capital Management sold 79,600 Humana shares in Q3 2025, an estimated $19.5M.
  • Soleus Capital Management first reported a position in Humana in Q4 2019 and held it in 11 quarters.
  • Soleus Capital Management's Humana position peaked at $33.7M in Q4 2023.
  • 890 funds tracked by Wall St. Rank held Humana as of Q3 2025.

Based on Soleus Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.